MRI After Technically Successful Renal Cryoablation: Early Contrast Enhancement as a Common Finding

被引:36
作者
Porter, Christopher A. [1 ]
Woodrum, David A. [1 ]
Callstrom, Matthew R. [1 ]
Schmit, Grant D. [1 ]
Misra, Sanjay [1 ]
Charboneau, J. William [1 ]
Atwell, Thomas D. [1 ]
机构
[1] Mayo Clin, Dept Radiol, Rochester, MN 55905 USA
关键词
cryotherapy; kidney; MRI; postablation imaging; RESONANCE-IMAGING FINDINGS; TUMORS; EXPERIENCE; MODEL;
D O I
10.2214/AJR.09.2518
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
OBJECTIVE. The purpose of this study was to assess the MRI appearance and enhancement of renal masses within 36 hours after cryoablation. MATERIALS AND METHODS. From March 2003 through January 2008, 129 patients underwent imaging-guided cryoablation for renal masses. Twenty-three of these patients underwent MRI within 36 hours after ablation. During MRI, acquisition of axial T1- and T2-weighted images was followed by administration of a gadolinium contrast agent. Standard follow-up included MRI 3-6 months after ablation. RESULTS. Eight of the 23 renal masses imaged within 6-36 hours after ablation were enhanced on MR images. Five of the eight lesions exhibited homogeneous enhancement, and the other three had heterogeneous or rim enhancement. Seven of the eight lesions exhibited no enhancement at the 6-month follow-up examination. One patient underwent follow-up imaging 10 months rather than 3-6 months after the procedure, but no enhancement was seen. T2-weighted signal intensity was mixed among the 23 renal masses. T1-weighted signal intensity was mixed among the 23 renal masses and the eight lesions that became enhanced, but there was a trend for higher T1 signal intensity at the 3- to 6-month follow-up examination. CONCLUSION. The high proportion of enhancing lesions 3 months after treatment and the resolution of enhancement 6 months afterward suggest that it may be reasonable to wait 6 months after technically successful renal cryoablation before performing contrast-enhanced MRI.
引用
收藏
页码:790 / 793
页数:4
相关论文
共 38 条
  • [31] Early effects of an x-ray contrast medium on renal T2*/T2 MRI as compared to short-term hyperoxia, hypoxia and aortic occlusion in rats
    Arakelyan, K.
    Cantow, K.
    Hentschel, J.
    Flemming, B.
    Pohlmann, A.
    Ladwig, M.
    Niendorf, T.
    Seeliger, E.
    ACTA PHYSIOLOGICA, 2013, 208 (02) : 202 - 213
  • [32] Renal Lesions with Low-level Enhancement on Contrast-enhanced CT Promotes Early Detection of Drug-induced Kidney Injury in Patients Administered Anti-cancer Drugs
    Chai, Xiao-Ming
    Yang, Xiu-Rong
    Li, Ying-Li
    Li, Zi-Yan
    Mi, Yan-Jun
    CURRENT MEDICAL IMAGING, 2024, 20
  • [33] Mid-term outcome of transarterial embolization of renal artery pseudoaneurysm and arteriovenous fistula after partial nephrectomy screened by early postoperative contrast-enhanced CT
    Morita, Satoru
    Matsuzaki, Yuka
    Yamamoto, Takahiro
    Kamoshida, Kumi
    Yamazaki, Hiroshi
    Tajima, Tsuyoshi
    Kondo, Tsunenori
    Takagi, Toshio
    Yoshida, Kazuhiko
    Tanabe, Kazunari
    Sakai, Shuji
    CVIR ENDOVASCULAR, 2020, 3 (01)
  • [34] T1-Weighted Contrast Enhancement, Apparent Diffusion Coefficient, and Cerebral-Blood-Volume Changes after Glioblastoma Resection: MRI within 48 Hours vs. beyond 48 Hours
    Negroni, Davide
    Bono, Romina
    Soligo, Eleonora
    Longo, Vittorio
    Cossandi, Christian
    Carriero, Alessandro
    Stecco, Alessandro
    TOMOGRAPHY, 2023, 9 (01) : 342 - 351
  • [35] Image quality of early postoperative CT angiography with reduced contrast material and radiation dose using model-based iterative reconstruction for screening of renal pseudoaneurysms after partial nephrectomy
    Morita, Satoru
    Ogawa, Yuko
    Yamamoto, Takahiro
    Kamoshida, Kumi
    Yamazaki, Hiroshi
    Suzuki, Kazufumi
    Sakai, Shuji
    Kunihara, Motoki
    Takagi, Toshio
    Tanabe, Kazunari
    EUROPEAN JOURNAL OF RADIOLOGY, 2020, 124
  • [36] Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)
    Gampenrieder, Simon Peter
    Peer, Andreas
    Weismann, Christian
    Meissnitzer, Matthias
    Rinnerthaler, Gabriel
    Webhofer, Johanna
    Westphal, Theresa
    Riedmann, Marina
    Meissnitzer, Thomas
    Egger, Heike
    Federspiel, Frederike Klaassen
    Reitsamer, Roland
    Hauser-Kronberger, Cornelia
    Stering, Katharina
    Hergan, Klaus
    Mlineritsch, Brigitte
    Greil, Richard
    BREAST CANCER RESEARCH, 2019, 21 (1)
  • [37] Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR)
    Simon Peter Gampenrieder
    Andreas Peer
    Christian Weismann
    Matthias Meissnitzer
    Gabriel Rinnerthaler
    Johanna Webhofer
    Theresa Westphal
    Marina Riedmann
    Thomas Meissnitzer
    Heike Egger
    Frederike Klaassen Federspiel
    Roland Reitsamer
    Cornelia Hauser-Kronberger
    Katharina Stering
    Klaus Hergan
    Brigitte Mlineritsch
    Richard Greil
    Breast Cancer Research, 21
  • [38] The clinical value of MRI using single-shot echoplanar DWI to identify liver involvement in patients with advanced gastroenteropancreatic-neuroendocrine tumors (GEP-NETs), compared to FSE T2 and FFE T1 weighted image after i.v. Gd-EOB-DTPA contrast enhancement
    Sankowski, Artur J.
    Cwikla, Jaroslaw B.
    Nowicki, Miroslaw L.
    Chaberek, Slawomir
    Pech, Maciej
    Lewczuk, Anna
    Walecki, Jerzy
    MEDICAL SCIENCE MONITOR, 2012, 18 (05): : MT33 - MT40